OBJECTIVES: To examine 6-month change in life-space mobility as a predictor of subsequent 6-month mortality in community-dwelling older adults. DESIGN: Prospective cohort study. SETTING: Community-dwelling older adults from five Alabama counties in the University of Alabama at Birmingham (UAB) Study of Aging. PARTICIPANTS: A random sample of 1,000 Medicare beneficiaries, stratified according to sex, race, and rural or urban residence, recruited between November 1999 and February 2001, followed by a telephone interview every 6 months for the subsequent 8.5 years. MEASUREMENTS: Mortality data were determined from informant contacts and confirmed using the National Death Index and Social Security Death Index. Life-space was measured at each interview using the UAB Life-Space Assessment, a validated instrument for assessing community mobility. Eleven thousand eight hundred seventeen 6-month life-space change scores were calculated over 8.5 years of follow-up. Generalized linear mixed models were used to test predictors of mortality at subsequent 6-month intervals. RESULTS: Three hundred fifty-four deaths occurred within 6 months of two sequential life-space assessments. Controlling for age, sex, race, rural or urban residence, and comorbidity, life-space score and life-space decline over the preceding 6-month interval predicted mortality. A 10-point decrease in life-space resulted in a 72% increase in odds of dying over the subsequent 6 months (odds ratio = 1.723, P < .001). CONCLUSIONS: Life-space score at the beginning of a 6-month interval and change in life-space over 6 months were each associated with significant differences in subsequent 6-month mortality. Life-space assessment may assist clinicians in identifying older adults at risk of short-term mortality. J Am Geriatr Soc 65:833-838, 2017.
M
obility is an important measure of overall health. Performance-based measures of mobility such as gait speed are predictive of mortality in community-dwelling older adults. 1, 2 Performance-based measures can be difficult to incorporate into clinical or public health practice, 3 so self-reported ratings of performance-based measures can be substituted in such circumstances. Self-reported walking difficulty is one of the strongest predictors of mortality in older adults. 4 Similarly, self-reported difficulty walking one-quarter of a mile is associated with greater odds of mortality over the subsequent 12 months. 5 The University of Alabama at Birmingham (UAB) Study of Aging Life-Space Assessment (LSA) is an alternative self-reported measure that assesses mobility in the community in which persons report distance, frequency, and independence of movement ranging from one's room to beyond one's town. 6, 7 As a measure of mobility, lifespace would be expected to have strong associations with mortality risk. Life-space offers several advantages over self-reported measures of walking or activities of daily living (ADLs). The LSA measures the full continuum of mobility in community-dwelling older adults, with very few persons reporting the lowest or highest levels, 6, 7 whereas other scales based on level of disability often have ceiling effects in this population. Furthermore, the LSA incorporates use of assistive devices in measurement of mobility, which other instruments may not adequately capture.
Two studies 9, 10 have demonstrated associations between life-space and long-term mortality. These associations remained even after adjusting for performance measures and comorbidity, indicating that life-space provides information beyond physical measurements of mobility and that the relationship is not entirely due to comorbid illnesses restricting mobility. Nevertheless, the effect of life-space on short-term (<1 year) mortality remains unclear. Furthermore, studies have focused on the lifespace score and have not examined mortality associated with changes in life-space over time. The purpose of this study was to determine whether assessment of life-space mobility and change in life-space mobility over 6 months of follow-up predicted mortality in community-dwelling older adults during a subsequent 6-month follow-up interval.
METHODS

Participants
The UAB Study of Aging was designed to understand subject-specific factors predisposing older adults to mobility decline. Participants were a stratified random sample of 1,000 Medicare beneficiaries aged 65 and older living in the community in five central Alabama counties. Oversampling was used to achieve balance in terms of race, sex, and rural residence. Trained interviewers conducted baseline in-home interviews between November 1999 and February 2001 after obtaining informed consent. Telephone follow-up interviews to assess life-space and vital status (alive or dead) were conducted at 6-month intervals. If participants were unable to complete follow-up assessments, designated contact persons were interviewed for this information (2.3% of interviews). The UAB institutional review board approved the study protocol. Details of study methods have been described elsewhere.
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Measures
Life-Space
The UAB LSA 6,7 is a validated measure of life-space mobility based on distance through which a person reports moving during the 4 weeks preceding the assessment. The composite measure incorporates life-space level, frequency with which it is attained, and degree of independence based on reported use of assistive equipment or help from another person. The composite score ranges from 0 to 120, with higher scores indicating greater mobility. 6, 7 Lifespace declines gradually with normal aging and changes acutely over months in association with life events such as hospitalization. 6, 12 Life-space was assessed at baseline and at each 6-month interval over 8.5 years of follow-up. Thus, participants who were alive and had no missing assessments could contribute up to 16 life-space scores to this analysis.
Mortality
Mortality over 8.5 years was initially determined according to report of family or designated contact and review of local obituaries for dates of death. Dates of death were confirmed through the National Death Index and Social Security Death Index. Final determination of vital status for all participants was made at the conclusion of the 8.5-year follow-up period.
Sociodemographic Factors
Age, sex, and race were self-reported at baseline interview. Marital status was classified as married or not married. Education was categorized as 6th grade or less, 7th through 11th grade, high school graduate, and some college or beyond. Location was defined as urban or rural based on county of residence.
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Comorbidity A comorbidity score was calculated based on the Charlson Comorbidity Index, 14 without consideration of severity, from data collected during the baseline in-home assessment. Comorbidities were considered verified if the participant reported the condition and took medication for the condition, if the condition was reported on a questionnaire returned from the participant's physician, or if the condition was noted on a hospital discharge summary that the research team reviewed.
Cognition
Cognition was assessed at baseline using the Mini-Mental State Examination (MMSE), 15 which includes items related to orientation, registration, recall, attention, and visuospatial construction. Scores range from 0 to 30, with higher scores representing better cognition.
Depression
Depressive symptoms were assessed at baseline using the 15-item Geriatric Depression Scale (GDS). 16 Scores range from 0 to 15, with a score of 6 or higher suggesting possible depression. 17 
Function
Function was assessed during baseline in-home assessments according to self-reported difficulty in performing ADLs (bathing, dressing, transferring, toileting, feeding oneself; range 0-15) and instrumental ADLs (IADLs; light and heavy housework, using the telephone, preparing meals, shopping, managing money; range 0-18). 18 Higher scores represent more difficulty.
Statistical Analyses
Characteristics of participants who died during the study were compared with characteristics of those alive at the end of the study using chi-square tests for categorical variables and t-tests for continuous variables. Generalized linear mixed models (GLMMs) 19 with a logistic link function were used to determine significant associations between life-space at the beginning of each 6-month interval, change in life-space over the same 6-month interval, and mortality over the subsequent 6-month interval. A 10-point difference in life-space scores was considered clinically meaningful based on prior reports, 6, 12, 20 although smaller differences may still be clinically significant. 21 An example of a 10-point difference would be an older person who previously reported no need for assistance to go into the neighborhood daily and to town one to three times per week (64 points) but now requires a cane to go into town less than once a week (54 points). Age at the time of interview, race, sex, urban or rural residence, cognition, depressive symptoms, baseline ADLs and IADLs, and Charlson Comorbidity Index were included as covariates based on previous reports of associations with life-space. 6, 7 Interaction terms were included to examine differences in lifespace based on race and sex and to examine whether the effect of life-space on mortality differed based on level of comorbidity. Sensitivity analyses using only observations in the first 6 months of the study were also conducted to minimize changes in covariates from baseline values. Finally, GLMMs were used to estimate probability of death over a 6-month period using life-space at the beginning and end of the prior 6-month period and adjusting for covariates. All statistical analyses were conducted using the glmmADMB package 22 version 0.8.3.3 for R version 3.2.2 (R Core Team, Vienna, Austria).
RESULTS
Participant Characteristics
Over the 8.5-year follow-up period, 398 participants (39.8%) died, and 602 were alive at the end of the study. Participant characteristics are shown in Table 1 . Participants who died were older, more likely to be male, and had lower education than those who survived. Participants who died also had lower cognitive scores, higher depression scores, more ADL and IADL impairments, and more comorbidities at baseline. Mean baseline life-space for subjects who died was 56.2, in contrast to 69.3 for those who remained alive (P < .001).
Life-Space and Short-Term Mortality
Of the 1,000 participants, 971 completed at least two sequential life-space assessments and contributed data to the logistic GLMM. The characteristics of these participants were similar to those of the whole sample. A total of 11,817 life-space change scores were calculated across adjacent 6-month intervals. Of the 11,817 intervals, 11,349 were followed by a 6-month period during which mortality could be determined; the participant died in 354 of the subsequent 6-month observation periods, whereas the participant survived in 10,995 of the subsequent 6-month periods. Over 8.5 years of follow-up, 44 participants who died did not have a life-space score at the beginning and end of the previous 6-month interval from which a change score could be calculated, so their final observation (but not prior observations) were excluded from the analysis. These participants differed from other participants who died during follow-up in race and length of follow-up but not other characteristics. Mean 6-month decrease in life-space for survivors was 1.2 AE 16.0 points, and mean 6-month decrease in life-space for participants who died was 8.0 AE 19.1 points. Mean life-space scores at the beginning of the 6-month interval were 59.7 AE 25.0 for survivors and 38.4 AE 23.9 for participants who died. Table 2 shows the final logistic GLMM assessing the effect of 6-month change in life-space score on mortality in the subsequent 6-month follow-up interval after adjusting for covariates.
The odds ratio for 6-month change in life-space suggested that, after adjusting for covariates, a 10-point decrease in life-space over a 6-month period increased the odds of dying over the subsequent 6-month interval by 72%. Likewise, for every 10 points that a person's lifespace score was lower than that of other individuals at the beginning of a 6-month interval, odds of dying over the next 6-month interval (within the next full year) was 92% greater. The model showed that other significant independent predictors of mortality included age, race, sex, education, and Charlson Comorbidity Index. There was significant interaction between comorbidity and life-space indicating that the effect of comorbidity on mortality was attenuated with higher life-space scores. In sensitivity analyses using only observations in the first 6 months of the study, a trend remained for life-space change associated Participants (N = 1,000) were classified based on whether death occurred at any time during the 8.5 years of follow-up, as determined according to the National Death Index or the Social Security Death Index. All participant characteristics were obtained at the baseline interview, with one participant missing information on the Geriatric Depression Scale. SD = standard deviation.
with greater mortality after adjusting for covariates (P = .051); life-space score at the beginning of the interval was no longer significant (data not shown). Table 3 provides subsequent 6-month mortality probability estimates as a function of life-space at the beginning and end of a 6-month interval. Six-month mortality ranged from less than 1% for those at the highest levels of life-space to 19.5% for those at the lowest levels, after adjusting for age, sex, race, education, and comorbidity. (Other covariates were excluded because they were not significant in the multivariate model.) Acute declines in lifespace, occurring over 6 months or less, were associated with sizeable increases in mortality, with much smaller increases associated with life-space score at the beginning of the interval. Decline to a life-space score of 20 or less conferred a 6-month mortality risk of 5.4% or greater, regardless of life-space score before decline.
Similarly, recovery of life-space scores from lower levels were associated with sizeable decreases in mortality, with much smaller decreases associated with life-space score at the beginning of the interval. Life-space scores of 70 or greater at the end of the 6-month interval was associated with mortality of less than 1% over the subsequent 6 months, regardless of life-space score before recovery.
DISCUSSION
Life-space mobility scores, measured using the LSA, predicted short-term changes in mortality in older community-dwelling men and women over the subsequent 6-month period. Change in life-space score over 6 months of follow-up also predicted mortality over the subsequent 6-month observation period, even after adjusting for lifespace at the beginning of the 6-month follow-up interval, age, sex, race, marital status, education, residence, cognition, depressive symptoms, baseline ADL and IADL ability, and comorbidity. Although previous studies have found an association between low life-space and greater mortality after 2.7 to 8 years, 9,10 the current study is the first to demonstrate effects of life-space on mortality over much shorter intervals. In this analysis, a decrease in lifespace score of 10 points resulted in 72% greater odds of mortality over the next 6 months. Thus, the amount of change in life-space mobility in a preceding 6-month interval and the absolute level of life-space mobility at the beginning of a follow-up interval will help identify older adults at risk of dying. Participants with persistently low life-space had the highest mortality risk, with 19.5% of those with a persistent life-space score of 0 dying over the next 6 months, although declines to low life-space levels had a high mortality risk even if participants began at the highest life-space levels, though risk was not as great as for participants beginning at low life-space levels. Conversely, participants who recovered to a high life-space level had low mortality risk even if they began at a low life-space level. These results suggest that intensive evaluations or interventions to address modifiable risk factors for decline in mobility, particularly in individuals with preexisting low life-space, may help reduce mortality. The effects of change in life-space on mortality remained in sensitivity analyses even after adjusting for comorbidity, suggesting that greater risk of mortality with a decrease in life-space was not entirely due to greater comorbidity that limited community mobility.
Several mechanisms might explain the relationship between life-space and mortality. The LSA reflects not only physical performance but also socioeconomic, cognitive, and emotional factors influencing mobility in the community 23 that are related to mortality and may serve as a Odds of mortality is shown over a 6-month period based on life-space (LS) scores at the beginning of the previous 6-month period and change in life-space score over the previous 6-month period. All covariates represent values collected at baseline.
broad measure of the overall well-being of the individual. The LSA may also capture effects of disease and symptom severity, which would presumably affect mortality, better than comorbidity measures that classify diseases as present or absent. Finally, social support, 23 which may affect mortality by affecting access to care for individuals with limited mobility, influences life-space scores. Future studies with concurrent assessment of life-space with each of these potential mediators will be needed to clarify proximate causes of changes in mobility that influence mortality risk.
A particular strength of this study is the examination of short-term effects of life-space on mortality in a large sample of community-dwelling older adults that included men and women and African Americans and Caucasians, which addresses shortcomings of previous studies. 9, 10 The focus on short-term mortality in this study is clinically relevant, because it suggests the possibility of interventions to improve life-space that might lead to reductions in mortality and provides prognostic guidance for those with marked mobility decline. Nevertheless, significant limitations remain. This analysis was limited to changes in lifespace mobility scores that occurred over a 6-month period because data were not available at more frequent intervals. Future research should examine the relationship between acuity of life-space change and subsequent adverse outcomes. Comorbidity, ADLs, and IADLs were assessed only at baseline, and any interim changes predicting mortality would not have been measured.
In summary, the current study demonstrated that lifespace scores and change in life-space are significantly associated with risk of mortality over the subsequent 6 months. Life-space can serve as a simple yet effective method of risk assessment in older adults and for identifying individuals for interventions to preserve mobility that could reduce mortality in this population.
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